economic
CSL signs deal with Trump administration to slash prices for its medicines
Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.
Reported by Sydney Morning Herald
Read the complete report at Sydney Morning Herald ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
Sydney Morning HeraldCSL signs deal with Trump administration to slash prices for its medicinesThe AgeCSL signs deal with Trump administration to slash prices for its medicines1 recorded state
Source report indexedP1 · 72% quality · 2 sources